Nov 07, 2022 / 11:00PM GMT
Ryan Weispfenning - Medtronic plc - VP of IR
All right. Good afternoon. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations Investor. Welcome at the Investor Briefing here at the American Heart Association Annual Scientific Sessions in Chicago. Thanks to you that are here in the room with us today. I appreciate you coming to Chicago and also a big welcome to those that are joining us around the world today on our webcast.
The next slide. Before we get started, I want to note that we could make some comments that maybe considered forward-looking statements, and actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. I encourage you to go back and read this slide.
The slides we are presenting today will be available for download shortly after the completion of today's event on our website at
Medtronic PLC Renal Denervation Investor & Analyst Briefing Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers